
Rhode Island's attorney general announced settlements worth $107 million against Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and AbbVie Inc's (NYSE:ABBV) Allergan unit to resolve claims over their roles in the opioid epidemic.
According to the Reuters report, the settlements include $28.5 million in cash, plus the delivery of anti-overdose treatments - 1 million Naloxone sprays and 67,000 bottles of Suboxone pills - over 10 years, to Rhode Island.